Kintara Therapeutics Inc (KTRA)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current KTRA market cap is 419.63M. The company's latest EPS is USD -0.1527 and P/E is -25.02.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.96M | -1.02M | -2.09M | -2.39M | -2.21M |
| Net Income | -3.14M | -1.03M | -2.01M | -2.33M | -2.18M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.2M | -38.17M | -22.68M | -14.8M | -8.45M |
| Net Income | -9.14M | -41.5M | -22.66M | -15.02M | -8.5M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.48M | 1.89M | 7.45M | 6.2M | 4.14M |
| Total Liabilities | 3.5M | 2.05M | 1.52M | 2.45M | 2.45M |
| Total Equity | -2.03M | -164k | 5.92M | 3.76M | 1.7M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.94M | 13.54M | 15.95M | 3.98M | 6.2M |
| Total Liabilities | 2.68M | 2.96M | 4.15M | 3.25M | 2.45M |
| Total Equity | 263k | 10.58M | 11.8M | 731k | 3.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.32M | -3.43M | -5.73M | -7.18M | -1.89M |
| Investing | N/A | -20k | -20k | -20k | N/A |
| Financing | -2k | 2.58M | 10.57M | 10.57M | N/A |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.93M | -18.86M | -20.39M | -11.87M | -7.18M |
| Investing | N/A | 964k | N/A | -232k | -20k |
| Financing | 6.6M | 26.04M | 21.64M | 1.85M | 10.57M |
| Market Cap | 419.63M |
| Price to Earnings Ratio | -25.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 43.31 |
| Price to Book Ratio | 56.59 |
| Dividend Yield | - |
| Shares Outstanding | 55.66M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 144.77% |
| 52 Week High | 14.595 |
| 52 Week Low | 3.01 |
| Spread (Intraday) | 0 (0.05%) |
| Company Name | Kintara Therapeutics Inc |
| Address |
50 west liberty street reno, nevada 89501 |
| Website | https://www.kintara.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
